Table 3.
Cmpd | L | R1, R2, R3 | EC50 (μM)b | S9 stability T1/2 (min) |
||
---|---|---|---|---|---|---|
Influenza | MeV | human | hamster | |||
3 | - | - | 0.5 | 0.74 | 19 | <2.5 |
12 | R1=R2=R3=4-H | 0.4 | 6.0 | 15 | 3 | |
14a | R1=R2=R3=4-F | 8.0 | 5.0 | <2.5 | <2.5 | |
14b | R1=R2=R3=H | >10 | >10 | NDc | ND | |
15 | R1=R2=R3=4-F | >10 | >10 | >90 | 54 | |
23a | R1=R2=R3=H | >10 | >10 | 27 | <2.5 | |
24a | R1=R2=H, R3=2-F | 10.0 | 9.0 | ND | ND | |
24b | R1=R2=H, R3=2-NO2 | 6.0 | 9.0 | ND | ND | |
25 | Rl=R2=R3=H | 10 | >10 | >90 | 5 | |
26 | Rl=R2=R3=H | >10 | >10 | ND | ND | |
27 | Rl=R2=R3=H | 10.0 | 6.0 | ND | ND | |
28a | Rl=R2=R3=H | 0.88 | 0.91 | 165 | <5.0 | |
28b | R1=R2=H, R3=4-OH | 10 | 10 | ND | ND | |
28c | R1=R2=H, R3=2-COOH | 3 | 3 | ND | ND | |
28d | R1=R2=H, R3=2-Py | 10 | 10 | ND | ND | |
32a | R1=R2=R3=H | >10 | >10 | ND | ND | |
32b | R1=R2=R3=H | 10 | 10 | ND | ND |
Lacks 1-methyl group on imidazole ring.
50% inhibitory concentration were calculated using the variable slope (four parameters) non-linear regression-fitting algorithm embedded in the Prism 5 software package (GraphPad Software). Values represent averages of four assessments; highest concentration assessed,10 μM.
Not determined when EC50 >10 μM.